Kevin Leach Announced as AxoGen, Inc New VP of Marketing

Kevin Leach

AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Kevin Leach as Vice President of Marketing effective March 14, 2016. Mr. Leach will report directly to Karen Zaderej, President and Chief Executive Officer and will be responsible for AxoGen’s global marketing strategies…

Read More

Distracted Walking – 2016 Public Service Announcement 

Distracted Walking

The American Academy of Orthopaedic Surgeons (AAOS) today unveiled its 2016 public service announcement (PSA) campaign which will be distributed to more than 8,000 media outlets across the country. This year’s multimedia program—television, radio and print PSAs—warns Americans on how to prevent serious injuries, and promotes: The dangers of distracted walking; The importance of safe,…

Read More

Medtronic Spine is Still Hobbled Over 

Medtronic

Medtronic reported its fiscal third quarter financial results on Tuesday where it reported slightly lower-than-expected revenue, most likely because of currency fluctuations. Most analysts described the results as solid, but one analyst’s question to Medtronic’s CEO, Omar Ishrak, underscored the nagging under performance of the Irish company’s spine division. In the quarter ended Jan.29, the…

Read More

Wenzel Spine Snags FDA Approval to Launch VariLift LX

wenzel spine

  Wenzel Spine, Inc. Announces FDA Clearance to Launch VariLift®-LX – The Next Generation Zero-Profile Stand-Alone Expandable Lumbar Interbody Fusion Device AUSTIN, Texas–(BUSINESS WIRE)–Wenzel Spine, Inc., a pioneer medical device company focused on providing minimally invasive, stand-alone alternatives to traditional spinal fusion, announced today that it received clearance from the U.S. Food and Drug Administration…

Read More

Bionic implant the size of a matchstick could help paralyzed people ‘walk with the power of thought’

The team is hoping to test the matchstick-sized stent electrode, or "stentrode," in a group of paralyzed patients with spinal cord injuries in 2017.

The team is hoping to test the matchstick-sized stent electrode, or “stentrode,” in a group of paralyzed patients with spinal cord injuries in 2017. The device is inserted via a blood vessel and is deposited in a blood vessel next to the motor cortex – the part of the brain that generates signals that control…

Read More

Corin Wins Summary Judgement in Metal-on-Metal Hip Suit

Corin

On February 3, 2016, Corin Group PLC and Corin USA Limited (Corin) prevailed in a lawsuit alleging injuries from Corin’s hip resurfacing system, the Cormet, a Class III medical device approved by the U.S. Food and Drug Administration (Swisher v. Stryker Corporation, et al.). After full discovery, Corin filed motions for summary judgment and to…

Read More

Hernia Patients, Surgeons Not Always Aligned for Pain Relief

Pain Relief

Chicago—Patients with ventral hernias say pain relief is the most important outcome that could affect their quality of life, rating it above fear of potential complications or any limits to their functioning, according to a new survey study. Furthermore, at follow-up interviews six months after their initial surgical consult, patients who had undergone surgical repair…

Read More

SI-BONE: New Positive Local Coverage Determination

SI-BONE

SI-BONE, Inc., manufacturers of the iFuse Implant System, has announced that CGS Administrators, LLC (CGS) the Medicare Administrative Contractor (MAC) covering the states of Kentucky and Ohio has issued a positive local coverage determination (LCD) for MIS SI joint fusion. iFUse is a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of…

Read More

SurgaColl Technologies firm seeks €15m for bone-repair technology

SurgaColl Technologies

A fledgling Irish medtech company is looking to raise €15 million to develop and commercialize revolutionary technology that will allow doctors to repair bone and cartilage in patients. SurgaColl Technologies has just received European approval to market its first product, a highly porous biodegradable sponge scaffold containing the main constituent elements of bone – collagen…

Read More

UW center receives $16M to work on first implantable device to reanimate paralyzed limbs

reanimate paralyzed limbs

In the next decade, people who have suffered a spinal cord injury or stroke could have their mobility improved or even restored through a radically new technology: implantable devices that can send signals between regions of the brain or nervous system that have been disconnected due to injury. That’s the mission driving the Center for Sensorimotor…

Read More